Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Urgently reviewing AstraZeneca COVID-19 vaccine trial data, says Britain medical regulator Ruchika Sharma11 Sept 2020 8:45 AM ISTUK: Britain's medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca AZN.L can restart...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
COVID-19: Pharma firms sign vaccine safety pledge MD Bureau9 Sept 2020 1:45 PM ISTThe CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have signed the pledge.
AstraZeneca halts COVID19 vaccine trial after recipient unexplained illness Ruchika Sharma9 Sept 2020 1:05 PM ISTNew York: Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's...
COVID-19 Vaccine: AstraZeneca AZD1222 phase 1/2 trials to begin in Japan Ruchika Sharma6 Sept 2020 9:15 AM ISTTokyo: Astrazeneca said on Friday it is beginning Phase 1/2 clinical trials in Japan of its coronavirus vaccine candidate.Trials of the vaccine, known...
AstraZeneca diabetes drug dapagliflozin shows significant benefits in CKD patients Ruchika Sharma3 Sept 2020 3:33 PM ISTBangalore: AstraZeneca India has announced the full results from the clinical trials of it's latest diabetes drug, dapagliflozin, showing...
AstraZeneca COVID vaccine reached Phase 3 clinical trials in US: Trump Medical Dialogues Bureau1 Sept 2020 9:30 AM ISTWashington DC: US President Donald Trump has announced that the vaccine for coronavirus being developed by AstraZeneca NSE 1.12 % has reached phase...
Oxford COVID vaccine phase 2 trial to begin in PGI Chandigarh MD Bureau29 Aug 2020 9:30 AM ISTPGI Chandigarh has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between the Indian...
Oxford COVID vaccine Phase 2 trial begins at Pune hospital MD Bureau27 Aug 2020 10:00 AM ISTNew Delhi : The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two...
Serum Institute shuns reports of commercializing Covishield, says will sell only after successful trial MD Bureau24 Aug 2020 1:30 PM IST"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.
India will get COVID-19 vaccine by 2020 end: Union Health Minister MD Bureau24 Aug 2020 12:45 PM ISTThe Ministry of Health and Family Welfare said that one of the three Covid-19 vaccine candidates has entered the third phase of the pre- clinical...
